Re: CALA management, unfortunately subpar 2.0
"CALA management completely screwed themselves and their investors with the timing of recent secondary."
Perhaps in the absence of a CFO, Susan is displaying some administrative weakness, but it doesn't change anything except to perhaps create a buying op for the family trust...and whomever else sees advantage. We are so very much closer to solid data with higher patient numbers than last time this stock ran, and the prospect of early registration might be the only catalyst necessary for a run back toward $20. A BTD announcement for -839 would be a compelling ingredient, and could come anytime leading up to an ESMO presentation.